HBM Gets Health Boost Through Drug Licensing (Undefined: HBMHF)

deliormanli

While China’s pharmaceutical sector struggles through tough times, some biotechs are still managing to push new drugs and make money.

HBM Holdings Ltd. (OTCPK: HBMHF) (2142.HK), for example, has found strength in numbers, a remarkable drug development